esomeprazole brands

5 registered brands containing esomeprazole in Uganda.

Esomeprazole

PubChem CID 9568614

Molecular formula: C17H19N3O3S

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole's duration of antisecretory effect that persists longer than 24 hours. Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. The S- and R-isomers of omeprazole are protonated and converted in the acidic compartment of the parietal cell forming the active inhibitor, the achiral sulphenamide. By acting specifically on the proton pump, esomeprazole blocks the final step in acid production, thus reducing gastric acidity. This effect is dose-related up to a daily dose of 20 to 40 mg and leads to inhibition of gastric acid secretion.

Source: PubChem (NCBI) ยท compound 9568614

Product Manufacturer Status Country
CLARTHROMYCIN + ESOMEPRAZOLE MAGNESIUM DIHYDRATE + TINIDAZOLE
ORAL SOLID ORDINARY FILM-COATED TABLETS
- Registered Uganda
ESOMEPRAZOLE
ORAL SOLID ORDINARY TABLETS
Astra Zeneca Registered Uganda
ESOMEPRAZOLE
PARENTERAL ORDINARY VIALS
Astra Zeneca Registered Uganda
ESOMEPRAZOLE
ORAL SOLID ORDINARY FILM-COATED TABLETS
Astrazeneca Registered Uganda
ESOMEPRAZOLE (AS MAGNESIUM TRIHYDRATE)
ORAL SOLID ORDINARY GRANULES
Astra Zeneca Registered Uganda